Rubicon Research IPO Day 3: Our Company was originally incorporated on May 6, 1999 as “Rubicon Research Limited” We are a pharmaceutical formulations company, driven by innovation through focused research and development Company.
As on 31, March 2024, we had a Portfolio of 69 active ANDA & New Drug Application Products approved by the US FDA including 55 Commercialized products.
our Company’s portfolio includes 66 Commercialized Products as of March 31, 2025.
we have 17 new products awaiting US FDA ANDA approval and 63 product candidates in various stages of development.
one major chronic disease, such as heart disease, cancer, diabetes, obesity, and hypertension.
- Expenditure for new technology development and cloud infrastructure.
- Expenditure for lease payments for our offices.
- Expenditure for marketing activities.
- General corporate purposes.
Rubicon Research IPO Offer Details
Issue Size: Rubicon Research IPO size is a Book Building Issue of ₹1,377.50 Cr, Consisting of a Fresh issue of ₹500.00 Cr and the Offer For Sale is ₹877.50 Cr.
Price Band: The Price band of Rubicon Research IPO is fixed at ₹461 to ₹485 per equity share.
Lead Managers of Issue: Axis Capital Limited, IIFL Capital Services Limited, JM Financial Limited and SBI Capital Markets Limited for Lead Managers of this IPO.
Issue Registrar: MUFG Intime India Private Limited
Listing Date: All shares included in the offer will be listed on NSE and BSE Stock Exchange on Oct 16, 2025.
Also Read : Rubicon Research IPO: Listing Price, GMP, Date, Review & Details
Rubicon Research subscription status Day 3 –
| Day to day | (QIBs) Qualified Institutional Buyers | ( NII ) Non-Institutional Investors | (RIIs) Retail Individual Investors | Total Subscription Status |
|---|---|---|---|---|
| Day 1 | 0.27 | 0.49 | 1.43 | 0.54 |
| Day 2 | 2.22 | 1.92 | 4.16 | 2.49 |
| Day 3 | 9.77 | 55.77 | 21.61 | 24.44 |
IPO Funds Utilisation:
The Company will use the proceeds from this IPO for the following purposes and activities:
- Prepayment or scheduled repayment of all or a portion of certain outstanding borrowings availed by our Company.
- Funding inorganic growth through unidentified acquisitions and other strategic initiatives and General corporate purposes.
More Upcoming IPOs to Watch on BSE & NSE:
Also Read: Canara Robeco AMC IPO Day 3: Check GMP, Subscription Status and Key Highlights
Rubicon Research IPO GMP price Details :
The GMP Price of Rubicon Research IPO on 13 October 2025 was ₹95, if we talk about the estimated listing price then it is ₹580, if we look at the estimated per share percentage of this stock then 19.59% listing gain can be obtained in this IPO.
Source: Investorgain.com Report dated 13 October 2025
Disclaimer: GMP (Grey Market Premium) price is just an unverified market news and does not have any concrete basis yet. The information given above is based on the news published in some media reports, it is for information purposes only. Investors should do their own study/research before taking their decision. We are not involved in the grey market in any way, nor do any trading or recommend doing grey market trading.
Disclaimer: This news is for stock market educational purposes only. The securities/investments mentioned here are not recommendatory.
